Open access · US-GOV via ClinicalTrials.gov Clinical trial

Hypofractionated Imrt (Vmat-Ra) With Temozolomide For Elderly Patients, Unsuitable For Surgery With Newly Diagnosed High Grade Glioma

Authors not listed

Istituto Clinico Humanitas · 2013

Dysbiosis Human Randomized controlled trial

Abstract

To assess the effect of IMRT using VMAT rapidarc approach, followed by adjuvant temozolomide on survival and quality of life in elderly, poor performance status patients with newly diagnosed HGG.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-25 MST

Cite this

APA

Anonymous. (2013). Hypofractionated Imrt (Vmat-Ra) With Temozolomide For Elderly Patients, Unsuitable For Surgery With Newly Diagnosed High Grade Glioma. <em>Istituto Clinico Humanitas</em>. https://clinicaltrials.gov/study/NCT02099487

Vancouver

Anonymous. Hypofractionated Imrt (Vmat-Ra) With Temozolomide For Elderly Patients, Unsuitable For Surgery With Newly Diagnosed High Grade Glioma. Istituto Clinico Humanitas. 2013.

BibTeX

@misc{anon2013Hypofr, title = {Hypofractionated Imrt (Vmat-Ra) With Temozolomide For Elderly Patients, Unsuitable For Surgery With Newly Diagnosed High Grade Glioma}, author = {Anonymous}, journal = {Istituto Clinico Humanitas}, year = {2013}, }